| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 06/03/2013 | 22h57 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 14/02/2013 | 21h57 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 07/02/2013 | 22h29 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 23h12 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 23h10 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 23h10 | Edgar (US Regulatory) | Definitive Materials Filed by Investment Companies. (497) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 22h30 | GlobeNewswire Inc. | Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/02/2013 | 22h41 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/02/2013 | 22h32 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 01/02/2013 | 23h06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 01/02/2013 | 23h04 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 28/01/2013 | 18h21 | Zacks | PTX Reduces Sales Force, CFO Quits - Analyst Blog | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 18/01/2013 | 22h23 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 19h15 | Zacks | Pernix Acquires Cypress and Hawthorn - Analyst Blog | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 01h02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 01h01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00h46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |